Thus, in a study of 3,916 BC samples, the production of PD-L1 by cells of the immune system was determined in 6%, and by tumor cells in 1.7% of biopsies with pronounced differences depending on the type of tumor (19% for the basal-like subtype of BC) [6]. This evidence concerns the gene CD274 and neoplasm.